Urgent Contrast-Enhanced CT in a Patient With Prior Contrast Reaction and eGFR 24
A 58-year-old woman has 6 hours of severe abdominal pain out of proportion to her examination, a lactate of 3.8 mmol/L, and suspected acute mesenteric ischemia. Six years ago she developed hives and facial swelling after a CT with intravenous contrast; she was treated with diphenhydramine and was not intubated. Her eGFR is now 24 mL/min/1.73 m², with creatinine rising from 1.9 to 2.4 mg/dL over 3 days. She takes metformin, an ACE inhibitor, and a beta blocker. The emergency physician requests CT with and without contrast immediately. The protocol nurse pages you because the departmental premedication policy requires 13 hours.
1. Do you give iodinated contrast? Argue both sides and commit to an answer.
Read the worked answer
The case for withholding: an eGFR of 24 with a rising creatinine puts her at genuine risk of contrast-associated AKI, which could mean dialysis, prolonged admission, and a further hit to an already tenuous kidney. She also has a documented prior reaction.
The case for giving it, which I find much stronger: the question being asked is whether she has an occluded superior mesenteric artery or vein, and contrast-enhanced CT angiography is the test that answers it. Noncontrast CT is inadequate for vascular assessment, and gadolinium-enhanced MR angiography in a patient with eGFR under 30 raises nephrogenic systemic fibrosis concerns enough to make it a poor substitute in an emergency.
The risk of missing mesenteric ischemia - a diagnosis with mortality well above 50% when treatment is delayed - dominates the risk of a possible, often reversible, creatinine bump.
My answer: give contrast, but optimize. Use low-osmolar contrast at the smallest diagnostic volume, obtain a single appropriate post-contrast phase rather than a true unenhanced-plus-enhanced pair, hydrate with isotonic saline, and hold the ACE inhibitor and metformin, rechecking renal function at 48 hours before restarting metformin. Document the risk discussion.
2. How do you handle the allergy history and the 13-hour premedication policy?
Read the worked answer
First, reconstruct the prior reaction - hives plus facial swelling treated only with diphenhydramine, without bronchospasm, hypotension, or intubation, is a moderate cutaneous reaction rather than a life-threatening one. Check whether that study was actually contrast-enhanced and which agent was used; misattribution is common.
Second, the policy is written for elective studies. A 13-hour oral regimen in a patient with a lactate of 3.8 and probable bowel ischemia would trade a small risk of a breakthrough reaction for a large risk of a bad outcome. The policy exists to serve the patient, not the reverse.
In practice: give intravenous methylprednisolone 40 mg (or hydrocortisone 200 mg) plus diphenhydramine 50 mg as tolerated, use a low-osmolar agent, and proceed. Have epinephrine, airway equipment, and a rapid-response plan immediately available, and monitor the patient through and after the injection. Note that the evidence that premedication prevents breakthrough reactions is weak - the mandatory elements are preparedness and speed.
If she had a history of anaphylaxis with intubation, the calculus shifts toward an alternative diagnosis pathway or a formal allergy consultation, but even then rarely toward a 13-hour delay in a surgical abdomen.
3. What do you document and to whom do you communicate, and what follow-up do you arrange?
Read the worked answer
Before the scan: a note stating the indication and time-critical nature, the prior reaction and its severity, the premedication actually given, the estimated renal function, the alternatives considered (noncontrast CT, MR angiography, ultrasound) and why they were rejected, and that the risk–benefit discussion occurred with the emergency physician. Name the responsible radiologist.
Communicate: the emergency physician and the surgical team directly, because a positive result changes their disposition immediately; the pharmacist, for the metformin and ACE inhibitor hold; and the primary team, for the 48-hour renal function check.
After the scan: review the creatinine trajectory at 48–72 hours and document whether AKI occurred - this is both good care and the data that makes the next urgent decision easier. Avoid any further iodinated contrast within the next 48–72 hours unless clearly necessary.
The underlying principle: when you deviate from a written policy for good reason, the documentation and the communication are the safeguard.